SAN DIEGO, Aug. 20, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) ( www.apricusbio.com) today announced a podium presentation entitled, "Nine months treatment with alprostadil cream (Vitaros®) results in sustained improvement of erectile function in males suffering from erectile dysfunction," will take place on Tuesday, August 28, 2012, at 2:30 p.m. CT as part of the upcoming World Meeting on Sexual Medicine ("WMSM"), which will take place in Chicago, IL, on August 26-30, 2012. The presentation will discuss the results of a subpopulation analysis of an open label dose titration efficacy and safety study to support Vitaros ® at the dose of 300 mcg in 100 mg of cream.
Apricus Biosciences Announces Podium Presentation Of Vitaros(R) Clinical Data At 2012 World Meeting On Sexual Medicine
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts